Mood and Decision-making in Methamphetamine Use Disorder
Part of paid clinical trials in Tulsa, Oklahoma.
- Sponsor
- Laureate Institute for Brain Research, Inc.
- Study ID
- NCT06410196
- Status
- Recruiting
Conditions
- Methamphetamine Abuse
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Mood modulation — BEHAVIORALAutobiographical memory recall designed to modulate mood and affective state by reminiscing about personal life events
Study Details
In this project, the investigators examine behavior and associated brain activity during explore-exploit decision-making tasks performed pre- and post-modulation of affective state using autobiographical memory recall. The investigators hypothesize that a positive memory recall will reduce negative affective state, reduce explore-exploit biases and normalize the associated brain activity. The investigators propose a randomized double-blind, sham-controlled trial of positive autobiographical memory recall with 80 adults (n=40 per arm) with methamphetamine use disorder (MUD) currently involved in abstinence only treatment centers.
Key Dates
- Start date
- Jul 26, 2024
- Status verified
- Sep 2025
- Primary completion
- Jul 1, 2027
- Completion
- Jul 1, 2027
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Active Comparator: Positive mood modulationUse of happy/positive autobiographical memories which are vivid, emotionally pleasurable and not drug-related, as assessed by individual interview and ratings
- Sham Comparator: Neutral mood modulationUse of neutral/procedural autobiographical memories which are vivid, emotionally neutral and not drug-related, as assessed by individual interview and ratings
Primary Outcome Measure
Current affective state [ Time Frame: Change from pre-intervention (baseline) to post-intervention (90min later) on study day 1 ]
Central Contacts
- Maëlle CM Gueguen, PhD918-502-5155
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Laureate Institute for Brain Research | Tulsa | Oklahoma | 74136 |
Find similar trials in Tulsa, OK
Related Studies
- Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic IncentivesRecruiting · Wake Forest University Health Sciences · Oconomowoc, Wisconsin
- Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use DisorderPHASE3 · Recruiting · National Institute on Drug Abuse (NIDA) · Little Rock, Arkansas
- Ketamine for Methamphetamine Use DisorderPHASE2 · Recruiting · University of Texas Southwestern Medical Center · San Leandro, California
- A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of MethamphetaminePHASE2 · Recruiting · Clear Scientific, Inc. · Glendale, California